1 | A bill to be entitled |
2 | An act relating to health care; amending s. 400.23, F.S.; |
3 | delaying a nursing home staffing increase; amending s. |
4 | 409.814, F.S.; granting more children access to the |
5 | Florida KidCare program; amending s. 409.903, F.S.; |
6 | deleting a provision eliminating eligibility for Medicaid |
7 | services for certain women; amending s. 409.904, F.S.; |
8 | providing for the Agency for Health Care Administration to |
9 | pay for medical assistance for certain Medicaid-eligible |
10 | persons; deleting a limitation on eligibility for coverage |
11 | under the medically needy program; amending s. 409.906, |
12 | F.S.; deleting a repeal of a provision that provides adult |
13 | denture services; repealing s. 409.9065, F.S., relating to |
14 | pharmaceutical expense assistance; amending s. 409.908, |
15 | F.S.; revising provisions relating to the long-term care |
16 | reimbursement and cost reporting system; revising |
17 | provisions relating to the Medicaid maximum allowable fee |
18 | for certain pharmacies; amending s. 409.912, F.S.; |
19 | revising components of the Medicaid prescribed-drug |
20 | spending-control program; authorizing the agency to |
21 | implement a program of all-inclusive care for certain |
22 | children; requiring a plan for comprehensive vision care |
23 | services; amending s. 409.9122, F.S.; deleting assignment |
24 | requirement for recipients in areas with capitated |
25 | behavioral health services; amending s. 409.9124, F.S.; |
26 | requiring the agency to develop managed care rates for |
27 | children of specified ages and to amend the methodology |
28 | for reimbursing managed care plans to comply therewith; |
29 | limiting the amount of reimbursement; providing effective |
30 | dates. |
31 |
|
32 | Be It Enacted by the Legislature of the State of Florida: |
33 |
|
34 | Section 1. Paragraph (a) of subsection (3) of section |
35 | 400.23, Florida Statutes, is amended to read: |
36 | 400.23 Rules; evaluation and deficiencies; licensure |
37 | status.-- |
38 | (3)(a) The agency shall adopt rules providing for the |
39 | minimum staffing requirements for nursing homes. These |
40 | requirements shall include, for each nursing home facility, a |
41 | minimum certified nursing assistant staffing of 2.3 hours of |
42 | direct care per resident per day beginning January 1, 2002, |
43 | increasing to 2.6 hours of direct care per resident per day |
44 | beginning January 1, 2003, and increasing to 2.9 hours of direct |
45 | care per resident per day beginning July 1, 2006 2005. Beginning |
46 | January 1, 2002, no facility shall staff below one certified |
47 | nursing assistant per 20 residents, and a minimum licensed |
48 | nursing staffing of 1.0 hour of direct resident care per |
49 | resident per day but never below one licensed nurse per 40 |
50 | residents. Nursing assistants employed under s. 400.211(2) may |
51 | be included in computing the staffing ratio for certified |
52 | nursing assistants only if they provide nursing assistance |
53 | services to residents on a full-time basis. Each nursing home |
54 | must document compliance with staffing standards as required |
55 | under this paragraph and post daily the names of staff on duty |
56 | for the benefit of facility residents and the public. The agency |
57 | shall recognize the use of licensed nurses for compliance with |
58 | minimum staffing requirements for certified nursing assistants, |
59 | provided that the facility otherwise meets the minimum staffing |
60 | requirements for licensed nurses and that the licensed nurses so |
61 | recognized are performing the duties of a certified nursing |
62 | assistant. Unless otherwise approved by the agency, licensed |
63 | nurses counted toward the minimum staffing requirements for |
64 | certified nursing assistants must exclusively perform the duties |
65 | of a certified nursing assistant for the entire shift and shall |
66 | not also be counted toward the minimum staffing requirements for |
67 | licensed nurses. If the agency approved a facility's request to |
68 | use a licensed nurse to perform both licensed nursing and |
69 | certified nursing assistant duties, the facility must allocate |
70 | the amount of staff time specifically spent on certified nursing |
71 | assistant duties for the purpose of documenting compliance with |
72 | minimum staffing requirements for certified and licensed nursing |
73 | staff. In no event may the hours of a licensed nurse with dual |
74 | job responsibilities be counted twice. |
75 | Section 2. Subsections (2) and (5) of section 409.814, |
76 | Florida Statutes, are amended to read: |
77 | 409.814 Eligibility.--A child who has not reached 19 years |
78 | of age whose family income is equal to or below 200 percent of |
79 | the federal poverty level is eligible for the Florida KidCare |
80 | program as provided in this section. For enrollment in the |
81 | Children's Medical Services Network, a complete application |
82 | includes the medical or behavioral health screening. If, |
83 | subsequently, an individual is determined to be ineligible for |
84 | coverage, he or she must immediately be disenrolled from the |
85 | respective Florida KidCare program component. |
86 | (2) A child who is not eligible for Medicaid, but who is |
87 | eligible for the Florida KidCare program, may obtain health |
88 | benefits coverage under any of the other components listed in s. |
89 | 409.813 if such coverage is approved and available in the county |
90 | in which the child resides. However, a child who is eligible for |
91 | Medikids, including those eligible under subsection (5), may |
92 | participate in the Florida Healthy Kids program only if the |
93 | child has a sibling participating in the Florida Healthy Kids |
94 | program and the child's county of residence permits such |
95 | enrollment. |
96 | (5) A child whose family income is above 200 percent of |
97 | the federal poverty level or a child who is excluded under the |
98 | provisions of subsection (4) may apply for coverage and shall be |
99 | allowed to participate in the Florida KidCare program, excluding |
100 | the Medicaid program, but is subject to the following |
101 | provisions: |
102 | (a) The family is not eligible for premium assistance |
103 | payments and must pay the full cost of the premium, including |
104 | any administrative costs. |
105 | (b) The agency is authorized to place limits on enrollment |
106 | in Medikids by these children in order to avoid adverse |
107 | selection. The number of children participating in Medikids |
108 | whose family income exceeds 200 percent of the federal poverty |
109 | level must not exceed 10 percent of total enrollees in the |
110 | Medikids program. |
111 | (c) The board of directors of the Florida Healthy Kids |
112 | Corporation is authorized to place limits on enrollment of these |
113 | children in order to avoid adverse selection. In addition, the |
114 | board is authorized to offer a reduced benefit package to these |
115 | children in order to limit program costs for such families. The |
116 | number of children participating in the Florida Healthy Kids |
117 | program whose family income exceeds 200 percent of the federal |
118 | poverty level must not exceed 10 percent of total enrollees in |
119 | the Florida Healthy Kids program. |
120 | (d) Children described in this subsection are not counted |
121 | in the annual enrollment ceiling for the Florida KidCare |
122 | program. |
123 | Section 3. Subsection (5) of section 409.903, Florida |
124 | Statutes, is amended to read: |
125 | 409.903 Mandatory payments for eligible persons.--The |
126 | agency shall make payments for medical assistance and related |
127 | services on behalf of the following persons who the department, |
128 | or the Social Security Administration by contract with the |
129 | Department of Children and Family Services, determines to be |
130 | eligible, subject to the income, assets, and categorical |
131 | eligibility tests set forth in federal and state law. Payment on |
132 | behalf of these Medicaid eligible persons is subject to the |
133 | availability of moneys and any limitations established by the |
134 | General Appropriations Act or chapter 216. |
135 | (5) A pregnant woman for the duration of her pregnancy and |
136 | for the postpartum period as defined in federal law and rule, or |
137 | a child under age 1, if either is living in a family that has an |
138 | income which is at or below 150 percent of the most current |
139 | federal poverty level, or, effective January 1, 1992, that has |
140 | an income which is at or below 185 percent of the most current |
141 | federal poverty level. Such a person is not subject to an assets |
142 | test. Further, a pregnant woman who applies for eligibility for |
143 | the Medicaid program through a qualified Medicaid provider must |
144 | be offered the opportunity, subject to federal rules, to be made |
145 | presumptively eligible for the Medicaid program. Effective July |
146 | 1, 2005, eligibility for Medicaid services is eliminated for |
147 | women who have incomes above 150 percent of the most current |
148 | federal poverty level. |
149 | Section 4. Subsections (1) and (2) of section 409.904, |
150 | Florida Statutes, are amended to read: |
151 | 409.904 Optional payments for eligible persons.--The |
152 | agency may make payments for medical assistance and related |
153 | services on behalf of the following persons who are determined |
154 | to be eligible subject to the income, assets, and categorical |
155 | eligibility tests set forth in federal and state law. Payment on |
156 | behalf of these Medicaid eligible persons is subject to the |
157 | availability of moneys and any limitations established by the |
158 | General Appropriations Act or chapter 216. |
159 | (1)(a) From July 1, 2005, through December 31, 2005, |
160 | inclusive, a person who is age 65 or older or is determined to |
161 | be disabled, whose income is at or below 88 percent of federal |
162 | poverty level, and whose assets do not exceed established |
163 | limitations. |
164 | (b) Effective January 1, 2006, and subject to federal |
165 | waiver approval, a person who is age 65 or older or is |
166 | determined to be disabled, whose income is at or below 88 |
167 | percent of the federal poverty level, whose assets do not exceed |
168 | established limitations, and who is not eligible for Medicare, |
169 | or, if eligible for Medicare, is also eligible for and receiving |
170 | Medicaid-covered institutional care or hospice or home-based and |
171 | community-based services. The agency shall seek federal |
172 | authorization through a waiver to provide this coverage. |
173 | (2) A family, a pregnant woman, a child under age 21, a |
174 | person age 65 or over, or a blind or disabled person, who would |
175 | be eligible under any group listed in s. 409.903(1), (2), or |
176 | (3), except that the income or assets of such family or person |
177 | exceed established limitations. For a family or person in one of |
178 | these coverage groups, medical expenses are deductible from |
179 | income in accordance with federal requirements in order to make |
180 | a determination of eligibility. A family or person eligible |
181 | under the coverage known as the "medically needy," is eligible |
182 | to receive the same services as other Medicaid recipients, with |
183 | the exception of services in skilled nursing facilities and |
184 | intermediate care facilities for the developmentally disabled. |
185 | Effective July 1, 2005, the medically needy are eligible for |
186 | prescribed drug services only. |
187 | Section 5. Paragraph (b) of subsection (1) of section |
188 | 409.906, Florida Statutes, is amended to read: |
189 | 409.906 Optional Medicaid services.--Subject to specific |
190 | appropriations, the agency may make payments for services which |
191 | are optional to the state under Title XIX of the Social Security |
192 | Act and are furnished by Medicaid providers to recipients who |
193 | are determined to be eligible on the dates on which the services |
194 | were provided. Any optional service that is provided shall be |
195 | provided only when medically necessary and in accordance with |
196 | state and federal law. Optional services rendered by providers |
197 | in mobile units to Medicaid recipients may be restricted or |
198 | prohibited by the agency. Nothing in this section shall be |
199 | construed to prevent or limit the agency from adjusting fees, |
200 | reimbursement rates, lengths of stay, number of visits, or |
201 | number of services, or making any other adjustments necessary to |
202 | comply with the availability of moneys and any limitations or |
203 | directions provided for in the General Appropriations Act or |
204 | chapter 216. If necessary to safeguard the state's systems of |
205 | providing services to elderly and disabled persons and subject |
206 | to the notice and review provisions of s. 216.177, the Governor |
207 | may direct the Agency for Health Care Administration to amend |
208 | the Medicaid state plan to delete the optional Medicaid service |
209 | known as "Intermediate Care Facilities for the Developmentally |
210 | Disabled." Optional services may include: |
211 | (1) ADULT DENTAL SERVICES.-- |
212 | (b) Beginning January 1, 2005, The agency may pay for |
213 | dentures, the procedures required to seat dentures, and the |
214 | repair and reline of dentures, provided by or under the |
215 | direction of a licensed dentist, for a recipient who is 21 years |
216 | of age or older. This paragraph is repealed effective July 1, |
217 | 2005. |
218 | Section 6. Effective January 1, 2006, section 409.9065, |
219 | Florida Statutes, is repealed. |
220 | Section 7. Paragraph (b) of subsection (2) and subsection |
221 | (14) of section 409.908, Florida Statutes, are amended to read: |
222 | 409.908 Reimbursement of Medicaid providers.--Subject to |
223 | specific appropriations, the agency shall reimburse Medicaid |
224 | providers, in accordance with state and federal law, according |
225 | to methodologies set forth in the rules of the agency and in |
226 | policy manuals and handbooks incorporated by reference therein. |
227 | These methodologies may include fee schedules, reimbursement |
228 | methods based on cost reporting, negotiated fees, competitive |
229 | bidding pursuant to s. 287.057, and other mechanisms the agency |
230 | considers efficient and effective for purchasing services or |
231 | goods on behalf of recipients. If a provider is reimbursed based |
232 | on cost reporting and submits a cost report late and that cost |
233 | report would have been used to set a lower reimbursement rate |
234 | for a rate semester, then the provider's rate for that semester |
235 | shall be retroactively calculated using the new cost report, and |
236 | full payment at the recalculated rate shall be effected |
237 | retroactively. Medicare-granted extensions for filing cost |
238 | reports, if applicable, shall also apply to Medicaid cost |
239 | reports. Payment for Medicaid compensable services made on |
240 | behalf of Medicaid eligible persons is subject to the |
241 | availability of moneys and any limitations or directions |
242 | provided for in the General Appropriations Act or chapter 216. |
243 | Further, nothing in this section shall be construed to prevent |
244 | or limit the agency from adjusting fees, reimbursement rates, |
245 | lengths of stay, number of visits, or number of services, or |
246 | making any other adjustments necessary to comply with the |
247 | availability of moneys and any limitations or directions |
248 | provided for in the General Appropriations Act, provided the |
249 | adjustment is consistent with legislative intent. |
250 | (2) |
251 | (b) Subject to any limitations or directions provided for |
252 | in the General Appropriations Act, the agency shall establish |
253 | and implement a Florida Title XIX Long-Term Care Reimbursement |
254 | Plan (Medicaid) for nursing home care in order to provide care |
255 | and services in conformance with the applicable state and |
256 | federal laws, rules, regulations, and quality and safety |
257 | standards and to ensure that individuals eligible for medical |
258 | assistance have reasonable geographic access to such care. |
259 | 1. Changes of ownership or of licensed operator do not |
260 | qualify for increases in reimbursement rates associated with the |
261 | change of ownership or of licensed operator. The agency shall |
262 | amend the Title XIX Long Term Care Reimbursement Plan to provide |
263 | that the initial nursing home reimbursement rates, for the |
264 | operating, patient care, and MAR components, associated with |
265 | related and unrelated party changes of ownership or licensed |
266 | operator filed on or after September 1, 2001, are equivalent to |
267 | the previous owner's reimbursement rate. |
268 | 2. The agency shall amend the long-term care reimbursement |
269 | plan and cost reporting system to create direct care and |
270 | indirect care subcomponents of the patient care component of the |
271 | per diem rate. These two subcomponents together shall equal the |
272 | patient care component of the per diem rate. Separate cost-based |
273 | ceilings shall be calculated for each patient care subcomponent. |
274 | The direct care and indirect care subcomponents subcomponent of |
275 | the per diem rate shall be limited by the cost-based class |
276 | ceiling, and the indirect care subcomponent shall be limited by |
277 | the lower of a the cost-based class ceiling, a by the target |
278 | rate class ceiling, or an by the individual provider target for |
279 | each subcomponent. The agency shall adjust the patient care |
280 | component effective January 1, 2002. The cost to adjust the |
281 | direct care subcomponent shall be the net of the total funds |
282 | previously allocated for the case mix add-on. The agency shall |
283 | make the required changes to the nursing home cost reporting |
284 | forms to implement this requirement effective January 1, 2002. |
285 | 3. The direct care subcomponent shall include salaries and |
286 | benefits of direct care staff providing nursing services |
287 | including registered nurses, licensed practical nurses, and |
288 | certified nursing assistants who deliver care directly to |
289 | residents in the nursing home facility. This excludes nursing |
290 | administration, MDS, and care plan coordinators, staff |
291 | development, and staffing coordinator. |
292 | 4. All other patient care costs shall be included in the |
293 | indirect care cost subcomponent of the patient care per diem |
294 | rate. There shall be no costs directly or indirectly allocated |
295 | to the direct care subcomponent from a home office or management |
296 | company. |
297 | 5. On July 1 of each year, the agency shall report to the |
298 | Legislature direct and indirect care costs, including average |
299 | direct and indirect care costs per resident per facility and |
300 | direct care and indirect care salaries and benefits per category |
301 | of staff member per facility. |
302 | 6. In order to offset the cost of general and professional |
303 | liability insurance, the agency shall amend the plan to allow |
304 | for interim rate adjustments to reflect increases in the cost of |
305 | general or professional liability insurance for nursing homes. |
306 | This provision shall be implemented to the extent existing |
307 | appropriations are available. |
308 |
|
309 | It is the intent of the Legislature that the reimbursement plan |
310 | achieve the goal of providing access to health care for nursing |
311 | home residents who require large amounts of care while |
312 | encouraging diversion services as an alternative to nursing home |
313 | care for residents who can be served within the community. The |
314 | agency shall base the establishment of any maximum rate of |
315 | payment, whether overall or component, on the available moneys |
316 | as provided for in the General Appropriations Act. The agency |
317 | may base the maximum rate of payment on the results of |
318 | scientifically valid analysis and conclusions derived from |
319 | objective statistical data pertinent to the particular maximum |
320 | rate of payment. |
321 | (14) A provider of prescribed drugs shall be reimbursed |
322 | the least of the amount billed by the provider, the provider's |
323 | usual and customary charge, or the Medicaid maximum allowable |
324 | fee established by the agency, plus a dispensing fee. |
325 | (a) For pharmacies with less than $75,000 in average |
326 | aggregate monthly payments, the Medicaid maximum allowable fee |
327 | for ingredient cost will be based on the lower of: average |
328 | wholesale price (AWP) minus 15.4 percent, wholesaler acquisition |
329 | cost (WAC) plus 5.75 percent, the federal upper limit (FUL), the |
330 | state maximum allowable cost (SMAC), or the usual and customary |
331 | (UAC) charge billed by the provider. |
332 | (b) For pharmacies with $75,000 or more in average |
333 | aggregate monthly payments, the Medicaid maximum allowable fee |
334 | for ingredient cost will be based on the lower of: average |
335 | wholesale price (AWP) minus 17 percent, wholesaler acquisition |
336 | cost (WAC) plus 3.5 percent, the federal upper limit (FUL), the |
337 | state maximum allowable cost (SMAC), or the usual and customary |
338 | (UAC) charge billed by the provider. |
339 | (c) Medicaid providers are required to dispense generic |
340 | drugs if available at lower cost and the agency has not |
341 | determined that the branded product is more cost-effective, |
342 | unless the prescriber has requested and received approval to |
343 | require the branded product. The agency is directed to implement |
344 | a variable dispensing fee for payments for prescribed medicines |
345 | while ensuring continued access for Medicaid recipients. The |
346 | variable dispensing fee may be based upon, but not limited to, |
347 | either or both the volume of prescriptions dispensed by a |
348 | specific pharmacy provider, the volume of prescriptions |
349 | dispensed to an individual recipient, and dispensing of |
350 | preferred-drug-list products. The agency may increase the |
351 | pharmacy dispensing fee authorized by statute and in the annual |
352 | General Appropriations Act by $0.50 for the dispensing of a |
353 | Medicaid preferred-drug-list product and reduce the pharmacy |
354 | dispensing fee by $0.50 for the dispensing of a Medicaid product |
355 | that is not included on the preferred drug list. The agency may |
356 | establish a supplemental pharmaceutical dispensing fee to be |
357 | paid to providers returning unused unit-dose packaged |
358 | medications to stock and crediting the Medicaid program for the |
359 | ingredient cost of those medications if the ingredient costs to |
360 | be credited exceed the value of the supplemental dispensing fee. |
361 | The agency is authorized to limit reimbursement for prescribed |
362 | medicine in order to comply with any limitations or directions |
363 | provided for in the General Appropriations Act, which may |
364 | include implementing a prospective or concurrent utilization |
365 | review program. |
366 | Section 8. Paragraph (a) of subsection (39) of section |
367 | 409.912, Florida Statutes, is amended, and subsections (50) and |
368 | (51) are added to said section, to read: |
369 | 409.912 Cost-effective purchasing of health care.--The |
370 | agency shall purchase goods and services for Medicaid recipients |
371 | in the most cost-effective manner consistent with the delivery |
372 | of quality medical care. To ensure that medical services are |
373 | effectively utilized, the agency may, in any case, require a |
374 | confirmation or second physician's opinion of the correct |
375 | diagnosis for purposes of authorizing future services under the |
376 | Medicaid program. This section does not restrict access to |
377 | emergency services or poststabilization care services as defined |
378 | in 42 C.F.R. part 438.114. Such confirmation or second opinion |
379 | shall be rendered in a manner approved by the agency. The agency |
380 | shall maximize the use of prepaid per capita and prepaid |
381 | aggregate fixed-sum basis services when appropriate and other |
382 | alternative service delivery and reimbursement methodologies, |
383 | including competitive bidding pursuant to s. 287.057, designed |
384 | to facilitate the cost-effective purchase of a case-managed |
385 | continuum of care. The agency shall also require providers to |
386 | minimize the exposure of recipients to the need for acute |
387 | inpatient, custodial, and other institutional care and the |
388 | inappropriate or unnecessary use of high-cost services. The |
389 | agency may mandate prior authorization, drug therapy management, |
390 | or disease management participation for certain populations of |
391 | Medicaid beneficiaries, certain drug classes, or particular |
392 | drugs to prevent fraud, abuse, overuse, and possible dangerous |
393 | drug interactions. The Pharmaceutical and Therapeutics Committee |
394 | shall make recommendations to the agency on drugs for which |
395 | prior authorization is required. The agency shall inform the |
396 | Pharmaceutical and Therapeutics Committee of its decisions |
397 | regarding drugs subject to prior authorization. The agency is |
398 | authorized to limit the entities it contracts with or enrolls as |
399 | Medicaid providers by developing a provider network through |
400 | provider credentialing. The agency may limit its network based |
401 | on the assessment of beneficiary access to care, provider |
402 | availability, provider quality standards, time and distance |
403 | standards for access to care, the cultural competence of the |
404 | provider network, demographic characteristics of Medicaid |
405 | beneficiaries, practice and provider-to-beneficiary standards, |
406 | appointment wait times, beneficiary use of services, provider |
407 | turnover, provider profiling, provider licensure history, |
408 | previous program integrity investigations and findings, peer |
409 | review, provider Medicaid policy and billing compliance records, |
410 | clinical and medical record audits, and other factors. Providers |
411 | shall not be entitled to enrollment in the Medicaid provider |
412 | network. The agency is authorized to seek federal waivers |
413 | necessary to implement this policy. |
414 | (39)(a) The agency shall implement a Medicaid prescribed- |
415 | drug spending-control program that includes the following |
416 | components: |
417 | 1. Medicaid prescribed-drug coverage for brand-name drugs |
418 | for adult Medicaid recipients is limited to the dispensing of |
419 | three four brand-name drugs and three generic drugs per month |
420 | per recipient. Children are exempt from this restriction. |
421 | Antiretroviral agents are excluded from this limitation. No |
422 | requirements for prior authorization or other restrictions on |
423 | medications used to treat mental illnesses such as |
424 | schizophrenia, severe depression, or bipolar disorder may be |
425 | imposed on Medicaid recipients. Medications that will be |
426 | available without restriction for persons with mental illnesses |
427 | include atypical antipsychotic medications, conventional |
428 | antipsychotic medications, selective serotonin reuptake |
429 | inhibitors, and other medications used for the treatment of |
430 | serious mental illnesses. The agency shall also limit the amount |
431 | of a prescribed drug dispensed to no more than a 34-day supply. |
432 | The agency shall continue to provide unlimited generic drugs, |
433 | contraceptive drugs and items, and diabetic supplies. Although a |
434 | drug may be included on the preferred drug formulary, it would |
435 | not be exempt from the three-brand four-brand limit or the |
436 | generic drug limit. The agency may authorize exceptions to the |
437 | brand-name-drug restriction based upon the treatment needs of |
438 | the patients, only when such exceptions are based on prior |
439 | consultation provided by the agency or an agency contractor, but |
440 | the agency must establish procedures to ensure that: |
441 | a. There will be a response to a request for prior |
442 | consultation by telephone or other telecommunication device |
443 | within 24 hours after receipt of a request for prior |
444 | consultation; |
445 | b. A 72-hour supply of the drug prescribed will be |
446 | provided in an emergency or when the agency does not provide a |
447 | response within 24 hours as required by sub-subparagraph a.; and |
448 | c. Except for the exception for nursing home residents and |
449 | other institutionalized adults and except for drugs on the |
450 | restricted formulary for which prior authorization may be sought |
451 | by an institutional or community pharmacy, prior authorization |
452 | for an exception to the brand-name-drug restriction is sought by |
453 | the prescriber and not by the pharmacy. When prior authorization |
454 | is granted for a patient in an institutional setting beyond the |
455 | brand-name-drug restriction, such approval is authorized for 12 |
456 | months and monthly prior authorization is not required for that |
457 | patient. |
458 | 2. Reimbursement to pharmacies for Medicaid prescribed |
459 | drugs shall be set at the lesser of: |
460 | a. The average wholesale price (AWP) minus 15.4 percent, |
461 | the wholesaler acquisition cost (WAC) plus 5.75 percent, the |
462 | federal upper limit (FUL), the state maximum allowable cost |
463 | (SMAC), or the usual and customary (UAC) charge billed by the |
464 | provider for pharmacies with less than $75,000 in average |
465 | aggregate monthly payments. |
466 | b. The average wholesale price (AWP) minus 17 percent, |
467 | wholesaler acquisition cost (WAC) plus 3.5 percent, the federal |
468 | upper limit (FUL), the state maximum allowable cost (SMAC), or |
469 | the usual and customary (UAC) charge billed by the provider for |
470 | pharmacies with $75,000 or more in average aggregate monthly |
471 | payments. |
472 | 3. The agency shall develop and implement a process for |
473 | managing the drug therapies of Medicaid recipients who are using |
474 | significant numbers of prescribed drugs each month. The |
475 | management process may include, but is not limited to, |
476 | comprehensive, physician-directed medical-record reviews, claims |
477 | analyses, and case evaluations to determine the medical |
478 | necessity and appropriateness of a patient's treatment plan and |
479 | drug therapies. The agency may contract with a private |
480 | organization to provide drug-program-management services. The |
481 | Medicaid drug benefit management program shall include |
482 | initiatives to manage drug therapies for HIV/AIDS patients, |
483 | patients using 20 or more unique prescriptions in a 180-day |
484 | period, and the top 1,000 patients in annual spending. The |
485 | agency shall enroll any Medicaid recipient in the drug benefit |
486 | management program if he or she meets the specifications of this |
487 | provision and is not enrolled in a Medicaid health maintenance |
488 | organization. |
489 | 4. The agency may limit the size of its pharmacy network |
490 | based on need, competitive bidding, price negotiations, |
491 | credentialing, or similar criteria. The agency shall give |
492 | special consideration to rural areas in determining the size and |
493 | location of pharmacies included in the Medicaid pharmacy |
494 | network. A pharmacy credentialing process may include criteria |
495 | such as a pharmacy's full-service status, location, size, |
496 | patient educational programs, patient consultation, disease- |
497 | management services, and other characteristics. The agency may |
498 | impose a moratorium on Medicaid pharmacy enrollment when it is |
499 | determined that it has a sufficient number of Medicaid- |
500 | participating providers. |
501 | 5. The agency shall develop and implement a program that |
502 | requires Medicaid practitioners who prescribe drugs to use a |
503 | counterfeit-proof prescription pad for Medicaid prescriptions. |
504 | The agency shall require the use of standardized counterfeit- |
505 | proof prescription pads by Medicaid-participating prescribers or |
506 | prescribers who write prescriptions for Medicaid recipients. The |
507 | agency may implement the program in targeted geographic areas or |
508 | statewide. |
509 | 6. The agency may enter into arrangements that require |
510 | manufacturers of generic drugs prescribed to Medicaid recipients |
511 | to provide rebates of at least 15.1 percent of the average |
512 | manufacturer price for the manufacturer's generic products. |
513 | These arrangements shall require that if a generic-drug |
514 | manufacturer pays federal rebates for Medicaid-reimbursed drugs |
515 | at a level below 15.1 percent, the manufacturer must provide a |
516 | supplemental rebate to the state in an amount necessary to |
517 | achieve a 15.1-percent rebate level. |
518 | 7. The agency may establish a preferred drug formulary in |
519 | accordance with 42 U.S.C. s. 1396r-8, and, pursuant to the |
520 | establishment of such formulary, it is authorized to negotiate |
521 | supplemental rebates from manufacturers that are in addition to |
522 | those required by Title XIX of the Social Security Act and at no |
523 | less than 14 percent of the average manufacturer price as |
524 | defined in 42 U.S.C. s. 1936 on the last day of a quarter unless |
525 | the federal or supplemental rebate, or both, equals or exceeds |
526 | 29 percent. There is no upper limit on the supplemental rebates |
527 | the agency may negotiate. The agency may determine that specific |
528 | products, brand-name or generic, are competitive at lower rebate |
529 | percentages. Agreement to pay the minimum supplemental rebate |
530 | percentage will guarantee a manufacturer that the Medicaid |
531 | Pharmaceutical and Therapeutics Committee will consider a |
532 | product for inclusion on the preferred drug formulary. However, |
533 | a pharmaceutical manufacturer is not guaranteed placement on the |
534 | formulary by simply paying the minimum supplemental rebate. |
535 | Agency decisions will be made on the clinical efficacy of a drug |
536 | and recommendations of the Medicaid Pharmaceutical and |
537 | Therapeutics Committee, as well as the price of competing |
538 | products minus federal and state rebates. The agency is |
539 | authorized to contract with an outside agency or contractor to |
540 | conduct negotiations for supplemental rebates. For the purposes |
541 | of this section, the term "supplemental rebates" means cash |
542 | rebates. Effective July 1, 2004, value-added programs as a |
543 | substitution for supplemental rebates are prohibited. The agency |
544 | is authorized to seek any federal waivers to implement this |
545 | initiative. |
546 | 8. The agency shall establish an advisory committee for |
547 | the purposes of studying the feasibility of using a restricted |
548 | drug formulary for nursing home residents and other |
549 | institutionalized adults. The committee shall be comprised of |
550 | seven members appointed by the Secretary of Health Care |
551 | Administration. The committee members shall include two |
552 | physicians licensed under chapter 458 or chapter 459; three |
553 | pharmacists licensed under chapter 465 and appointed from a list |
554 | of recommendations provided by the Florida Long-Term Care |
555 | Pharmacy Alliance; and two pharmacists licensed under chapter |
556 | 465. |
557 | 9. The Agency for Health Care Administration shall expand |
558 | home delivery of pharmacy products. To assist Medicaid patients |
559 | in securing their prescriptions and reduce program costs, the |
560 | agency shall expand its current mail-order-pharmacy diabetes- |
561 | supply program to include all generic and brand-name drugs used |
562 | by Medicaid patients with diabetes. Medicaid recipients in the |
563 | current program may obtain nondiabetes drugs on a voluntary |
564 | basis. This initiative is limited to the geographic area covered |
565 | by the current contract. The agency may seek and implement any |
566 | federal waivers necessary to implement this subparagraph. |
567 | 10. The agency shall limit to one dose per month any drug |
568 | prescribed to treat erectile dysfunction. |
569 | 11.a. The agency shall implement a Medicaid behavioral |
570 | drug management system. The agency may contract with a vendor |
571 | that has experience in operating behavioral drug management |
572 | systems to implement this program. The agency is authorized to |
573 | seek federal waivers to implement this program. |
574 | b. The agency, in conjunction with the Department of |
575 | Children and Family Services, may implement the Medicaid |
576 | behavioral drug management system that is designed to improve |
577 | the quality of care and behavioral health prescribing practices |
578 | based on best practice guidelines, improve patient adherence to |
579 | medication plans, reduce clinical risk, and lower prescribed |
580 | drug costs and the rate of inappropriate spending on Medicaid |
581 | behavioral drugs. The program shall include the following |
582 | elements: |
583 | (I) Provide for the development and adoption of best |
584 | practice guidelines for behavioral health-related drugs such as |
585 | antipsychotics, antidepressants, and medications for treating |
586 | bipolar disorders and other behavioral conditions; translate |
587 | them into practice; review behavioral health prescribers and |
588 | compare their prescribing patterns to a number of indicators |
589 | that are based on national standards; and determine deviations |
590 | from best practice guidelines. |
591 | (II) Implement processes for providing feedback to and |
592 | educating prescribers using best practice educational materials |
593 | and peer-to-peer consultation. |
594 | (III) Assess Medicaid beneficiaries who are outliers in |
595 | their use of behavioral health drugs with regard to the numbers |
596 | and types of drugs taken, drug dosages, combination drug |
597 | therapies, and other indicators of improper use of behavioral |
598 | health drugs. |
599 | (IV) Alert prescribers to patients who fail to refill |
600 | prescriptions in a timely fashion, are prescribed multiple same- |
601 | class behavioral health drugs, and may have other potential |
602 | medication problems. |
603 | (V) Track spending trends for behavioral health drugs and |
604 | deviation from best practice guidelines. |
605 | (VI) Use educational and technological approaches to |
606 | promote best practices, educate consumers, and train prescribers |
607 | in the use of practice guidelines. |
608 | (VII) Disseminate electronic and published materials. |
609 | (VIII) Hold statewide and regional conferences. |
610 | (IX) Implement a disease management program with a model |
611 | quality-based medication component for severely mentally ill |
612 | individuals and emotionally disturbed children who are high |
613 | users of care. |
614 | c. If the agency is unable to negotiate a contract with |
615 | one or more manufacturers to finance and guarantee savings |
616 | associated with a behavioral drug management program by |
617 | September 1, 2004, the four-brand drug limit and preferred drug |
618 | list prior-authorization requirements shall apply to mental |
619 | health-related drugs, notwithstanding any provision in |
620 | subparagraph 1. The agency is authorized to seek federal waivers |
621 | to implement this policy. |
622 | 12. The agency is authorized to contract for drug rebate |
623 | administration, including, but not limited to, calculating |
624 | rebate amounts, invoicing manufacturers, negotiating disputes |
625 | with manufacturers, and maintaining a database of rebate |
626 | collections. |
627 | 13. The agency may specify the preferred daily dosing form |
628 | or strength for the purpose of promoting best practices with |
629 | regard to the prescribing of certain drugs as specified in the |
630 | General Appropriations Act and ensuring cost-effective |
631 | prescribing practices. |
632 | 14. The agency may require prior authorization for the |
633 | off-label use of Medicaid-covered prescribed drugs as specified |
634 | in the General Appropriations Act. The agency may, but is not |
635 | required to, preauthorize the use of a product for an indication |
636 | not in the approved labeling. Prior authorization may require |
637 | the prescribing professional to provide information about the |
638 | rationale and supporting medical evidence for the off-label use |
639 | of a drug. |
640 | 15. The agency shall implement a return and reuse program |
641 | for drugs dispensed by pharmacies to institutional recipients, |
642 | which includes payment of a $5 restocking fee for the |
643 | implementation and operation of the program. The return and |
644 | reuse program shall be implemented electronically and in a |
645 | manner that promotes efficiency. The program must permit a |
646 | pharmacy to exclude drugs from the program if it is not |
647 | practical or cost-effective for the drug to be included and must |
648 | provide for the return to inventory of drugs that cannot be |
649 | credited or returned in a cost-effective manner. |
650 | (50) The agency may implement a program of all-inclusive |
651 | care for children to reduce the need for hospitalization of |
652 | children, as appropriate. The purpose of the program is to |
653 | provide in-home hospice-like support services to children |
654 | diagnosed with a life-threatening illness who are enrolled in |
655 | the Children's Medical Services Network. The agency, in |
656 | consultation with the Department of Health, may implement the |
657 | program of all-inclusive care for children after obtaining |
658 | approval from the Centers for Medicare and Medicaid Services. |
659 | (51) By July 1, 2005, the agency shall develop a plan for |
660 | implementing the delivery of comprehensive vision care services |
661 | to Medicaid recipients through a capitated prepaid arrangement. |
662 | The plan shall include contracting with a private entity or |
663 | entities to provide for the comprehensive vision care services |
664 | through a capitated prepaid arrangement. However, the entity |
665 | must: |
666 | (a) Be licensed under chapter 627. |
667 | (b) Have sufficient financial resources. |
668 | (c) Have a contracted provider network that has statewide |
669 | coverage. |
670 | (d) Have experience in providing medical and surgical |
671 | vision care services. |
672 | (e) Have experience with the implementation of large |
673 | statewide contracts. As used in this section, the term "vision |
674 | care services" means covered vision services, including routine, |
675 | medical, and surgical vision care services that are available to |
676 | Medicaid recipients. If necessary, the agency shall seek federal |
677 | approval to contract with a single entity meeting these |
678 | requirements to provide vision care services to all Medicaid |
679 | recipients. The entity must offer sufficient choice of providers |
680 | within its network to ensure access to care for the recipient |
681 | and the opportunity to select a provider with whom the recipient |
682 | is satisfied. |
683 | Section 9. Paragraph (k) of subsection (2) of section |
684 | 409.9122, Florida Statutes, is amended to read: |
685 | 409.9122 Mandatory Medicaid managed care enrollment; |
686 | programs and procedures.-- |
687 | (2) |
688 | (k) When a Medicaid recipient does not choose a managed |
689 | care plan or MediPass provider, the agency shall assign the |
690 | Medicaid recipient to a managed care plan, except in those |
691 | counties in which there are fewer than two managed care plans |
692 | accepting Medicaid enrollees, in which case assignment shall be |
693 | to a managed care plan or a MediPass provider. Medicaid |
694 | recipients in counties with fewer than two managed care plans |
695 | accepting Medicaid enrollees who are subject to mandatory |
696 | assignment but who fail to make a choice shall be assigned to |
697 | managed care plans until an enrollment of 40 percent in MediPass |
698 | and 60 percent in managed care plans is achieved. Once that |
699 | enrollment is achieved, the assignments shall be divided in |
700 | order to maintain an enrollment in MediPass and managed care |
701 | plans which is in a 40 percent and 60 percent proportion, |
702 | respectively. In geographic areas where the agency is |
703 | contracting for the provision of comprehensive behavioral health |
704 | services through a capitated prepaid arrangement, recipients who |
705 | fail to make a choice shall be assigned equally to MediPass or a |
706 | managed care plan. For purposes of this paragraph, when |
707 | referring to assignment, the term "managed care plans" includes |
708 | exclusive provider organizations, provider service networks, |
709 | Children's Medical Services Network, minority physician |
710 | networks, and pediatric emergency department diversion programs |
711 | authorized by this chapter or the General Appropriations Act. |
712 | When making assignments, the agency shall take into account the |
713 | following criteria: |
714 | 1. A managed care plan has sufficient network capacity to |
715 | meet the need of members. |
716 | 2. The managed care plan or MediPass has previously |
717 | enrolled the recipient as a member, or one of the managed care |
718 | plan's primary care providers or MediPass providers has |
719 | previously provided health care to the recipient. |
720 | 3. The agency has knowledge that the member has previously |
721 | expressed a preference for a particular managed care plan or |
722 | MediPass provider as indicated by Medicaid fee-for-service |
723 | claims data, but has failed to make a choice. |
724 | 4. The managed care plan's or MediPass primary care |
725 | providers are geographically accessible to the recipient's |
726 | residence. |
727 | 5. The agency has authority to make mandatory assignments |
728 | based on quality of service and performance of managed care |
729 | plans. |
730 | Section 10. Subsections (6) and (7) are added to section |
731 | 409.9124, Florida Statutes, to read: |
732 | 409.9124 Managed care reimbursement.-- |
733 | (6) The agency shall develop rates for children age 0-3 |
734 | months and separate rates for children age 4-12 months. The |
735 | agency shall amend the payment methodology for participating |
736 | Medicaid-managed health care plans to comply with this |
737 | subsection. |
738 | (7) The agency shall not pay rates at per-member per-month |
739 | averages higher than that allowed for in the General |
740 | Appropriations Act. |
741 | Section 11. Except as otherwise provided herein, this act |
742 | shall take effect July 1, 2005. |